非布司他中国上市价格

(Alias: Febuxostat) is used for the treatment of chronic hyperuricemia (gout); it is an effective non-purine selective inhibitor of xanthine oxidase (XO), which achieves the therapeutic effect of reducing serum uric acid by selectively inhibiting xanthine oxidase.

In 2013, febuxostat was launched in China. What is the price of febuxostat in China?

Price of Febuxostat: It is understood that the price of Febuxostat on the domestic market is relatively expensive and is not suitable for patients to take it for a long time. What I need to tell you here is that the efficacy of Febuxostat produced by Zydus Pharmaceutical Factory in India is the same as that of the original drug. The price is indeed much lower. The specification is 80mg*30 tablets/box. Its price is about 200$. Due to the floating exchange rate, the price is different. Please consult the medical companion for the specific price!

Precautions for Febuxostat (alias: Febuxostat):

1. Febuxostat is not recommended for patients with ischemic heart disease or congestive heart failure.

2. After starting to use febuxostat, an increase in gout attacks is common. This increase is due to a decrease in serum uric acid levels, resulting in mobilization of urate deposited in tissues. To prevent gout attacks when starting febuxostat, concomitant prophylactic treatment with a nonsteroidal anti-inflammatory drug or colchicine is recommended.

3. As with the use of other urate-lowering drugs, in patients with extremely increased urate formation rates (e.g., malignant diseases and their treatment, Lesch-Nyhan syndrome), in rare cases, the absolute concentration of xanthine in the urine can increase to the point where deposition occurs in the urinary tract. As there is no experience with its use (alias: febuxostat), its use in these populations is not recommended.

   Recommended related hot articles: /newsDetail/74640.html